- Cancer-like gene expression may occur in airway epithelium cells of healthy smokers
- A new pathway may lead to therapy for a lethal brain cancer
- The FDA approved glucarpidase to break down toxic levels of chemotherapy in the blood
- Epigenetic changes help form a strategy for retinoblastoma treatment
- Vismodegib was approved to treat advanced basal cell carcinoma patients
- Diindolylmethane enhances the effects of cisplatin in ovarian cancer cells
Category Archives: In the News
Blog Buzz: January 21 – January 27
Some topics getting buzz this week:
The debate on Avastin and breast cancer may have been rekindled by new studies.
The NY Times ArtsBeat covered a great example of innovation and the public use of digital library collections, which resulted in New York Public Library’s Stereogranimator, do-it-yourself 3D historical images!
Google’s announcement that it is putting 60 of its services under a single privacy policy and sharing data between them generated some buzz. This Washington Post/Bloomberg piece covers what is happening and how to close your account, while over at Scholarly Kitchen there is an interesting post asking The End of the Salad Days-Where is Google Headed Next?
Talk of the Research Works Act continues…an item by Jennifer Howard in the Chronicle of Higher Education discusses Who gets to see published research?, and the Modern Language Association (both a publisher and membership organization) released this letter.
ARL Policy Notes posted why the Association of Research Libraries’ new Code of Best Practices in Fair Use for Academic and Research Libraries is different from all the other recommendations out there.
MSKCC in the News: January 12 – January 25
- MSKCC researchers contributed to a study published in Pediatrics that found that the majority of pre-adolescents do not regularly use sunscreen despite the fact that many of them suffered sunburns at some point during their childhood, which increases the risk of developing melanoma later in life.
- Dr. Peter T. Scardino of MSKCC was quoted in a Huffington Post article about the implications of a recent study that found a new gene variant linked with a higher risk of developing hereditary prostate cancer.
- Researchers from MSKCC have shown in mouse models that a single dose of the commonly used antibiotic, clindamycin, wiped out nearly 90 percent of bacterial taxa, leaving the mice unusually susceptible to infection by Clostridium difficile.